additional navigation



A Pioneer in Rare Diseases

AOP Orphan was one of the first companies to enter the sector of rare diseases in Europe and to this day, continues to be a trailblazer in the field of Orphan Diseases. As a specialist in Orphan Diseases, AOP Orphan researches, develops, produces, and distributes innovative solutions in the following therapeutic areas: hematology and oncology, cardiology and pulmonology, neurology and psychiatry, and metabolic diseases. Today AOP Orphan is active at an international scale with an export ratio of about 70% and has become a leading company in its home branch.


Vienna, March 16, 2020 On Wednesday March 11 the World Health Organization (WHO) announced a pandemic in response to the COVID-19 outbreak. This is a serious health...

AOP Orphan Pharmaceuticals AG, the Austrian specialist for rare diseases, will implement ‘Mobile IntelligenceTM (MI)’ - the smart CRM Tool from leading Life-Sciences...

AOP Orphan Contact

AOP Orphan Germany

AOP Orphan worldwide

Products & Area of treatment